Tecan Group AG (TCHBF) Stock Price & Analysis
Tecan Group AG (TCHBF) — price $315.25 (0.00%), as of the Nov 19, 2026 trading session; market cap $3.88B.
Educational signal · not a buy or sell recommendation · How to read this
Tecan Group AG · TCHBF
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. The company operates through two segments: Life Sciences Business and Partnering Business.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $315.25 | |
| Change on the day | 0.00% | |
| 52-week range | $155.25 – $315.25 | |
| Market capitalisation | $3.88B | — |
| Shares traded on the day | 1 |
Price & events
Other perspectives
Council score for Tecan Group AG (TCHBF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
5 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: May 1, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On May 1, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Tecan Group AG (TCHBF), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Tecan Group AG (TCHBF) is the company analyzed here. It employs 3,244 people and is led by Monica Manotas. In Q2 FY2026 it reported revenue of CHF 425M and net income of CHF 12M. The market values it at $3.88B.
What do the latest results show for Tecan Group AG (TCHBF)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of CHF 425M. Against analyst estimates the company has EPS beat 5 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | CHF 425M | CHF 12M | CHF 0.98 (diluted) |
| Q4 FY2025 | CHF 443M | -CHF 129M | -CHF 10.15 (diluted) |
| Q2 FY2025 | CHF 439M | CHF 18M | CHF 1.41 (diluted) |
| Q4 FY2024 | CHF 467M | CHF 45M | CHF 3.54 (diluted) |
What are the financial strengths and risks for Tecan Group AG (TCHBF)?
Short answer · as of
The distress and quality screens read Altman Z 5.50 · Piotroski F 5. Trailing ratios: ROE -10.3% · ROA -7.1% · current ratio 2.32 · earnings yield -3.7% · free-cash-flow yield 1.8%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held TCHBF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported TCHBF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Tecan Group AG (TCHBF)?
What Investors Ask About Tecan Group AG (TCHBF)
These answers are editorial: 1 of these 8 answers is drawn from the TCHBF research dossier (written Mar 17, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is TCHBF a good stock to buy?
Stock Expert AI does not rate TCHBF buy, sell or hold. Tecan Group AG has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the TCHBF stock price today?
The last price recorded for Tecan Group AG (TCHBF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What revenue streams does Tecan Group AG have in healthcare?
Tecan Group AG generates revenue from several key streams within the healthcare sector. These include the sale of laboratory instruments and automation solutions to pharmaceutical and biotechnology companies, university research departments, and diagnostic laboratories. Revenue is also derived from the sale of consumables and reagents, as well as maintenance and support services for its instruments.
What are the key factors to evaluate for TCHBF?
Evaluate TCHBF on fundamentals, analyst consensus, and risk factors. Strategic Partnerships in Diagnostics: Forming strategic partnerships with diagnostic companies can drive growth for Tecan. Not financial advice.
How frequently does TCHBF data refresh on this page?
TCHBF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven TCHBF's recent stock price performance?
Tecan Group AG (TCHBF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong market position in laboratory automation. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider TCHBF overvalued or undervalued right now?
Tecan Group AG (TCHBF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research TCHBF before investing?
Before investing in Tecan Group AG (TCHBF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 14 figures on this page — 7 from Financial Modeling Prep (FMP) and 7 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com